175 related articles for article (PubMed ID: 21123289)
1. Which insulin, regimen and device in type 2 diabetes?
Drug Ther Bull; 2010 Dec; 48(12):134-8. PubMed ID: 21123289
[TBL] [Abstract][Full Text] [Related]
2. Why, when and how to initiate insulin therapy in patients with type 2 diabetes.
Tibaldi J; Rakel RE
Int J Clin Pract; 2007 Apr; 61(4):633-44. PubMed ID: 17394436
[TBL] [Abstract][Full Text] [Related]
3. The importance of titrating starting insulin regimens in patients with type 2 diabetes.
Garber AJ
Diabetes Obes Metab; 2009 Nov; 11 Suppl 5():10-3. PubMed ID: 19817778
[No Abstract] [Full Text] [Related]
4. New insulins and new insulin regimens: a review of their role in improving glycaemic control in patients with diabetes.
Crasto W; Jarvis J; Khunti K; Davies MJ
Postgrad Med J; 2009 May; 85(1003):257-67. PubMed ID: 19520878
[TBL] [Abstract][Full Text] [Related]
5. A clinical and health economic review of a prefilled insulin pen.
Niskanen L
Curr Med Res Opin; 2010 Oct; 26(10):2431-9. PubMed ID: 20815660
[TBL] [Abstract][Full Text] [Related]
6. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
Bode BW
Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
[TBL] [Abstract][Full Text] [Related]
7. A review of insulin pen devices.
McCoy EK; Wright BM
Postgrad Med; 2010 May; 122(3):81-8. PubMed ID: 20463417
[TBL] [Abstract][Full Text] [Related]
8. Insulin delivery by injection in children and adolescents with diabetes.
Hanas R; de Beaufort C; Hoey H; Anderson B
Pediatr Diabetes; 2011 Aug; 12(5):518-26. PubMed ID: 21481121
[TBL] [Abstract][Full Text] [Related]
9. Reusable and disposable insulin pens for the treatment of diabetes: understanding the global differences in user preference and an evaluation of inpatient insulin pen use.
Perfetti R
Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S79-85. PubMed ID: 20515312
[TBL] [Abstract][Full Text] [Related]
10. Insulin glargine and glulisine SoloSTAR pens for the treatment of diabetes.
Garg S; Kelly WC; Garg S
Expert Rev Med Devices; 2008 Mar; 5(2):113-23. PubMed ID: 18331174
[TBL] [Abstract][Full Text] [Related]
11. Overnight CSII as supplement to oral antidiabetic drugs in type 2 diabetes.
Parkner T; Møller MK; Chen JW; Laursen T; Jørgensen C; Smedegaard JS; Lauritzen T; Christiansen JS
Diabetes Obes Metab; 2008 Jul; 10(7):556-63. PubMed ID: 17593233
[TBL] [Abstract][Full Text] [Related]
12. Biphasic insulin aspart given thrice daily is as efficacious as a basal-bolus insulin regimen with four daily injections: a randomised open-label parallel group four months comparison in patients with type 2 diabetes.
Ligthelm RJ; Mouritzen U; Lynggaard H; Landin-Olsson M; Fox C; le Devehat C; Romero E; Liebl A
Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):511-9. PubMed ID: 17115349
[TBL] [Abstract][Full Text] [Related]
13. Devices for insulin administration.
Hill J
Nurs Times; 2003 Apr 15-21; 99(15):51-2. PubMed ID: 12733296
[TBL] [Abstract][Full Text] [Related]
14. Demonstrating strategies for initiation of insulin therapy: matching the right insulin to the right patient.
Meneghini L
Int J Clin Pract; 2008 Aug; 62(8):1255-64. PubMed ID: 18705822
[TBL] [Abstract][Full Text] [Related]
15. Insulin intensification strategies in type 2 diabetes: when one injection is no longer sufficient.
Garber AJ
Diabetes Obes Metab; 2009 Nov; 11 Suppl 5():14-8. PubMed ID: 19817779
[No Abstract] [Full Text] [Related]
16. [Guidelines concerning insulin dosage in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion].
Szypowska A; Pańkowska E; Lipka M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):45-50. PubMed ID: 16704861
[TBL] [Abstract][Full Text] [Related]
17. Considerations in insulin delivery device selection.
Valentine V; Kruger DF
Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S98-S100. PubMed ID: 20515315
[TBL] [Abstract][Full Text] [Related]
18. Intensive insulin therapy and insulin pumps.
Bode BW
Postgrad Med; 2002 Nov; 112(5 Suppl Designer):17-21. PubMed ID: 19667601
[TBL] [Abstract][Full Text] [Related]
19. Comparison of utilization, cost, adherence, and hypoglycemia in patients with type 2 diabetes initiating rapid-acting insulin analog with prefilled pen versus vial/syringe.
Lee LJ; Li Q; Reynolds MW; Pawaskar MD; Corrigan SM
J Med Econ; 2011; 14(1):75-86. PubMed ID: 21231863
[TBL] [Abstract][Full Text] [Related]
20. Premixed insulin treatment for type 2 diabetes: analogue or human?
Garber AJ; Ligthelm R; Christiansen JS; Liebl A
Diabetes Obes Metab; 2007 Sep; 9(5):630-9. PubMed ID: 17697056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
